No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial

Ditte Hansen, Knud Rasmussen, Henning Danielsen, Helmut Meyer-Hofmann, Egidijus Bacevicius, Thomas G Lauridsen, Jens K Madsen, Birgitte G Tougaard, Peter Marckmann, Peter Thye-Roenn, Jørgen E Nielsen, Svend Kreiner, Lisbet Brandi

Research output: Contribution to journalJournal articleResearchpeer-review

56 Citations (Scopus)
Original languageEnglish
JournalKidney International
Volume80
Pages (from-to)841-50
Number of pages10
ISSN0085-2538
DOIs
Publication statusPublished - 2011
Externally publishedYes

Keywords

  • Adult
  • Aged
  • Calcium
  • Cross-Over Studies
  • Ergocalciferols
  • Female
  • Humans
  • Hydroxycholecalciferols
  • Hyperparathyroidism, Secondary
  • Male
  • Middle Aged
  • Parathyroid Hormone
  • Phosphorus
  • Renal Dialysis

Fingerprint Dive into the research topics of 'No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial'. Together they form a unique fingerprint.

Cite this